Q4 2024 Adapthealth Corp Earnings Call Transcript
Key Points
- AdaptHealth Corp (AHCO) exceeded the high end of their guidance ranges for revenue, adjusted EBITDA, and free cash flow in Q4 2024.
- The Sleep Health and Respiratory Health segments showed year-over-year growth, with Sleep Health revenue increasing by 3.4% and Respiratory Health by 1%.
- Free cash flow was strong in Q4 2024 at $73 million, up 10% from the prior year quarter.
- The company made significant progress in their five areas of focus, including the One Adapt initiative and the application of AI and automation.
- AdaptHealth Corp (AHCO) reduced debt by $170 million in 2024, improving their net leverage ratio to 2.8 times.
- Fourth quarter adjusted EBITDA contracted by 2% from the prior year quarter.
- The Diabetes Health segment experienced a revenue decline of 7.3% in Q4 2024.
- Adjusted EBITDA margin for Q4 2024 was 23.4%, slightly narrower than the 23.8% reported in the prior year quarter.
- The company expects ongoing weakness in their Diabetes Health performance to impact Q1 2025 revenue.
- Free cash flow guidance for 2025 is lower at the midpoint compared to 2024, partly due to payment term extensions not recurring.
Good day, everyone, and welcome to today's AdaptHealth fourth quarter 2024 earnings release. Today's speakers will be Suzanne Foster, Chief Executive Officer of AdaptHealth; and Jason Clemens, Chief Financial Officer of AdaptHealth.
Before we begin, I would like to remind everyone that statements included in this conference call and in the press release issued today may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act. These statements include, but are not limited to, comments regarding financial results for 2025 and beyond. Actual results could differ materially from those projected in forward-looking statements because of a number of risk factors and uncertainties, which are discussed at length in the company's annual and quarterly SEC filings.
AdaptHealth Corp has no obligation to update the information provided on this call to reflect such subsequent events. Additionally, on this morning's call, the company will reference certain financial measures such as EBITDA, adjusted EBITDA, adjusted EBITDA margin and free cash flow, all
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
